Topic: off-label marketing
Given new life by prosecutors in 2017, France’s long-running Mediator case is now up for trial. Did Servier know the drug was killing patients?
The whistle continues to blow in a case alleging AstraZeneca defrauded Medicare by playing down the risks of its antipsychotic drug Seroquel, just not as loudly.
For pharma and a former Warner Chilcott manager, it could have been much worse. Ex-district manager Landon Eckles was sentenced to 1 year of probation and a fine of $10,000 for violating health privacy laws by filling out prior authorization forms for doctors who prescribed the Warner bone med Atelvia.
The Attorney General of New Hampshire is accusing Purdue Pharma of dragging its feet in his investigation into Purdue’s marketing of its highly addictive opioid Oxycontin.
Pharma marketers may have felt reprieved after a former Warner Chilcott sales chief was acquitted last month. But now, two former Johnson & Johnson execs have been convicted on off-label marketing charges, raising the specter of more prosecutions in the drug business.
Pfizer and the city of Chicago have hammered out an agreement on painkiller marketing, setting out a code of conduct to help ensure the powerful drugs are prescribed to the right patients and used with all their serious risks in mind.
The FDA has caught plenty of flak from drugmakers impatient for new off-label marketing guidelines. But now, a powerful congressional committee is blaming a higher authority--HHS Secretary Sylvia Burwell.